|
⚲
|
| Keyboard |
| Fred Mermelstein | |
|---|---|
| Firm | |
| Address | c/o Ipsen Biolabs 650 E Kendall Street Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Nextrna Therapeutics Inc | 021-431048 | Director | 23.4 M of 50.0 M |
||
| NX Pharmagen Inc | 021-374530 | Director | 0.5 M of 1.0 M |
||
| Sanarx Biotherapeutics Inc | 021-350382 | Director | 0.4 M of 1.2 M |
||
| NX Development Corp | 021-264008 | Director | 0.7 M of 2.9 M |
||
| Advantagene Inc | 021-261703 | Director | 14.2 M of 35.0 M |
||
| Advantagene Inc | 021-253495 | Director | 2.2 M of 2.5 M |
||
| NX Pharmagen Inc | 021-198568 | Director | 0.8 M of 1.0 M |
||